Company: IXHL
Filing Date: 2025-05-15
Form Type: 10-Q
Source: 0001213900-25-043682
Chunk: 5

Company: Incannex Healthcare Inc.
Filing Date: 2025-05-15
Form: 10-Q
Item: Part I, Item 1
Chunk 5
---
)

    For the nine months ended March 31, 

    2025  
    2024 
  
    Cash flows from operating activities: 

    Net loss 
    $(15,282) 
    $(11,998)
  
    Adjustments to reconcile net loss to net cash used in operating activities: 

    Depreciation and amortization 
     185  
     41 
  
    Unrealized gain on foreign currency remeasurement 
     338  
     17 
  
    Non-cash expense of ELOC commitment 
     1,097  
     - 
  
    Share-based compensation expense 
     1,311  
     5,585 
  
    Change in fair value of warrant liabilities 
     (1,721) 
     - 
  
    Change in fair value of convertible rights 
     179  
     - 
  
    Non-cash interest expense 
     303  
     - 
  
    Loss on extinguishment 
     994  
     - 
  
    Change in operating assets and liabilities: 
        
     - 
  
    Prepaid expenses and other current assets 
     148  
     (6,150)
  
    R&D tax incentive 
     2,222  
     - 
  
    Assets pledged as securities for short-term debt 
     (1,397) 
     - 
  
    Trade and other payables 
     592  
     302 
  
    Net cash used in operating activities 
     (11,031) 
     (12,203)
  
    Cash flows from investing activities: 

    Purchase of property, plant and equipment 
     (8) 
     (274)
  
    Net cash used in investing activities 
     (8) 
     (274)
  
    Cash flows from financing activities: 

    Proceeds received from facility agreement 
     4,282  
     - 
  
    Repayment of facility agreement 
     (2,898) 
     - 
  
    Proceeds from share issuance 
     12,446  

    Share issuance costs 
     (744) 
     - 
  
    Warrant issuance costs 
     (125) 
     - 
  
    Proceeds from issuance of convertible debt 
     2,779  
     -